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Over the last ten years, genome-wide association studies (GWAS) have reported over
4000 single nucleotide polymorphisms associated to more than 200 traits [1,2]. Despite
providing us with a slightly better understanding of the genetic architecture of com-
mon diseases, generating avalanches of new hypotheses, and fostering timid progress in
pharmacogenomics [3], genetic associations studies haven’t yet revolutionized clinical
practice [4]. Hence, although such studies are still published at a remarkable pace, the
notion of “post-GWAS” functional characterization of risk loci [2] is gradually gaining
in popularity. Indeed, deciphering the function of disease-associated genetic variants is
likely to get us closer to achieving an understanding of disease architecture that will
ultimately be translatable into clinical applications. Despite this gradual change in
research priorities, the field of medical genomics remains fairly conservative: the “single
gene single disease” paradigm largely prevails, to the detriment of the avant-garde
notion of “diseasome” [5] and of human disease network ("HDN”) in particular, and
attempts to truly integrate clinical information (e.g., age at onset or reduction in life
span) and molecular data are scarce. Here we call for a revival of the notion of disease
network, and recall how superimposing layers of clinical data and biological informa-
tion to such networks may help identify novel disease genes. An inspiring read in that
context is the recent paper by Barabási and coworkers on network medicine [6].
Diseases are traditionally considered as discrete entities and classified accordingly.
However, the networks of genes accountable for particular disease phenotypes most
certainly overlap, with individual genes simultaneously serving the cause of multiple
disorders [5,7]. Clinically distinct diseases have genes in common, like nodes in a net-
work have links in common, and DNs capture this analogy by representing diseases
with nodes and the genes they share with links. In such a network representation,
breast cancer and pancreatic cancer for instance are two nodes connected by TP53 [5].
What the concept of DN implies is that many susceptibility loci hitherto associated to
distinct diseases are in fact likely to contribute to the genetic architecture of several
disorders. Hence, rather than initiating genetic association studies with no a priori
hypothesis about where in the genome to look for potential candidate risk loci, the
information captured by HDNs may serve the purpose of anchoring the search for sus-
ceptibility loci in genomic regions known to harbor genetic variants predictive of other
“linked” diseases. Subsequently, the human inter a c t o m e[ 6 ] ,i . e . ,t h ec o m p e n d i u mo f
molecular, phenotypic and genetic interactions, or genome-wide regulatory networks
[8] can serve as maps to navigate the genome in search of further susceptibility loci.
Additional indices on where to start exploring the genome for susceptibility loci can
be inferred from general principles of human diseases and clinical data. For example, a
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reproduction in any medium, provided the original work is properly cited.considerable fraction of diseases with onset early in life appear to result from defects in
enzyme-encoding genes, whereas diseases with onset during adulthood appear to be
caused by alterations in genes encoding modifiers of protein functions [9]. Thus, clini-
cal information such as age at onset or severity can serve as valuable expert knowledge
to narrow down the genomic search space to genes or genetic domains that are biolo-
gically and clinically meaningful. Additionally, and although this is not always the case,
co-morbid disorders often share genes [6]. Hence, using well-established susceptibility
loci for co-morbid disorders as a starting point in genetic association studies may
further enhance the success rate of these endeavors.
Recent years have come with major advancements in candidate gene prioritization
and our understanding of the genetic architecture of human diseases is undoubtedly
progressing. Here we have suggested that biological and clinical information may serve
as valuable expert knowledge for genetic association studies and that disease networks
may provide useful guidance prior to and during data mining.
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